Home > Financial Ratios > NURECA

NURECA
Core EBITDA Growth

    Back to All Ratios
NURECA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NURECA
Please provide your vote to see the results

NURECA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 69.111,494.46103.88-112.51-1.79

What is the latest Core EBITDA Growth ratio of NURECA ?

The latest Core EBITDA Growth ratio of NURECA is 69.11 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202669.11
Mar20251,494.46
Mar2024103.88
Mar2023-112.51
Mar2022-1.79

How is Core EBITDA Growth of NURECA Trending?

Years Core EBITDA Growth % Change
Mar2026 69.11
-95.38
Mar2025 1494.46
1,338.64
Mar2024 103.88
Positive
Mar2023 -112.51
Negative
Mar2022 -1.79 -

Other Financial Ratios of NURECA


Compare Core EBITDA Growth ratio of peers of NURECA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NURECA ₹325.3 Cr 2.3% 6% 28% Stock Analytics
LENSKART SOLUTIONS ₹122,899.0 Cr 3.7% 10.5% NA Stock Analytics
POLY MEDICURE ₹17,512.7 Cr -0.6% -2.5% -15.4% Stock Analytics
3B BLACKBIO DX ₹1,138.9 Cr -6.8% 15.8% -9.6% Stock Analytics
LAXMI DENTAL ₹1,086.8 Cr -2.2% 1% -35.3% Stock Analytics
PREVEST DENPRO ₹458.9 Cr -6.1% -3.4% -37.8% Stock Analytics


NURECA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NURECA

2.3%

6%

28%

SENSEX

-0.8%

-3.8%

-8.9%


You may also like the below Video Courses